Neurotrope, Inc. (NTRP) is a publicly traded company in the Unknown sector. Across all available filings, 18 corporate insiders have executed 37 transactions totaling $234.1K, demonstrating a bullish sentiment with $228.9K in net insider flow. The most recent transaction on Nov 21, 2025 involved a transaction of 50,000 shares valued at $0.
No significant insider buying has been recorded for NTRP in the recent period.
No significant insider selling has been recorded for NTRP in the recent period.
Based on recent SEC filings, insider sentiment for NTRP is bullish with an Insider Alignment Score of 99/100 and a net flow of $228.9K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Neurotrope, Inc. (NTRP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 18 insiders are actively trading NTRP stock, having executed 37 transactions in the past 90 days. The most active insider is Charles S. Ramat (Executive), who has made 1 transactions totaling $1.0M.
Get notified when executives and directors at NTRP file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 21, 2025 | Don Byrd Jimmy | Executive | Conversion | 50,000 | $N/A | $0 | |
| Nov 21, 2025 | L. Diges Carmen | Executive | Conversion | 13,580 | $N/A | $0 | |
| Nov 21, 2025 | P. Monaco Donald | Executive | Conversion | 745,032 | $N/A | $0 | |
| Nov 21, 2025 | Kerby William | Executive | Conversion | 331,124 | $N/A | $0 | |
| Nov 21, 2025 | T. Jiang David | Executive | Conversion | 659,316 | $N/A | $0 | |
| Nov 21, 2025 | Patrick Mcmahon John | Executive | Conversion | 168,414 | $N/A | $0 | |
| Nov 21, 2025 | Jay Kaplan Andrew | Executive | Conversion | 31,250 | $N/A | $0 | |
| Nov 21, 2025 | C. Kircher Stephen | Executive | Conversion | 34,223 | $N/A | $0 | |
| Nov 4, 2025 | T. Jiang David | Executive | Other | 127,186 | $1.96 | $249.3K | |
| Aug 29, 2025 | Kerby William | Executive | Other | 102,579 | $N/A | $0 | |
| Aug 29, 2025 | P. Monaco Donald | Executive | Other | 102,579 | $N/A | $0 | |
| Jul 23, 2025 | Jay Kaplan Andrew | Executive | Purchase | 5,000 | $4.12 | $20.6K | |
| Dec 1, 2020 | Schechter Jonathan | Executive | Disposition | 50,000 | $N/A | $0 | |
| Dec 1, 2020 | Silverman Joshua | Executive | Disposition | 100,000 | $N/A | $0 | |
| Dec 1, 2020 | Weinstein Robert | Executive | Disposition | 3,953 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Conversion(C) | 12 | $1.1M | 69.0% |
Other(J) | 3 | $249.3K | 16.0% |
Purchase(P) | 13 | $231.5K | 14.8% |
Sale(S) | 2 | $2.6K | 0.2% |
Disposition(D) | 5 | $0 | 0.0% |
Exercise (Options)(X) | 2 | $0 | 0.0% |
Insiders at Neurotrope, Inc. are accumulating shares at an accelerated pace. With 18 insiders making 37 transactions totaling $231.5K in purchases versus $2.6K in sales, the net buying activity of $228.9K signals strong executive confidence. Charles S. Ramat (Executive) leads the buying activity with $1.0M in transactions across all time.